New publications from WG4

New publications from WG4

Share this post

Facebook
Twitter
LinkedIn
WhatsApp

🚀 Exciting News from working group 4 of IMMUNO-model! 🧬

We’re proud to announce the publication of four comprehensive review articles from Working Group 4, supported by the IMMUNO-model project! These articles explore key advancements in Cancer Immunity and Immunotherapy, contributing valuable insights to the scientific community.

📚 Dive into the research:

1️⃣ Unleashing the power of CAR-M therapy in solid tumors: a comprehensive review
🔗 https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2025.1615760/full
2️⃣ Challenges in the preclinical design and assessment of CAR-T cells
🔗 https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2025.1564998/abstract
3️⃣ CAR-NK cells: harnessing the power of natural killers for advanced cancer therapy
🔗 https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2025.1603757/full
4️⃣ Tumor-infiltrating lymphocytes in cancer immunotherapy: from chemotactic recruitment to translational modeling
🔗 https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2025.1601773/full

Latest Updates

In the scope of 1 month long STSM at the Science for life laboratory in Stockholm, Sweden, we combined advanced 3D glioblastoma models and different regions of glioblastoma tissue with...
Title: Engineered immune-competent models of metabolic dysfunction-associated steatotic liver disease and hepatocellular carcinoma using patient-derived hepatocyte organoids and biomaterials Start and end date: 16/02/2026 to 17/04/2026 I am Ana Margarida...
STSM: Short Term Scientific Mission Visit to a host organization located in a different country than the country of affiliation by a researcher or innovator for specific work to be...
Patients’ Webinar: Immunotherapy in Cancer – How It Works and Why Challenges Remain April 23rd, at 4 pm CETLive on TEAMs platform Speakers Dr. Uzma Hassan, CRCL – The Lyon...
The @immunomodel COST Action workshop MODELS, CHALLENGES AND PROMISES OF ADVANCED THERAPIES FOR CANCER: NK CELLS IN THE CLINIC AND INDUSTRY, organized by @MarValesLab CNB-CSIC, brought together leading international experts...
IMMUNO-model released Annual report for Grant Period 3, in which activities and achievements of IMMUNO-model are summarized

Join us

How to Participate

The COST Action IMMUNO-model welcomes research-active scientists working in the field.

How to Get Involved

  • Read the Project Description MoU;
  •  Inform the Main Proposer/Chair of your interest (email);
  • Apply to join your Working Groups of interest;
  • You will be informed by the working group leaders as soon as your application has been reviewed;
  • Please note, Management Committee nominations are carried out through the COST National Contact Points.

How to participate in an existing Action?

If you would like to join this COST Action please ensure that you read the guidance notes published on the COST website. You can find full documentation regarding general rules and guidelines for COST Actions at www.cost.eu/participate.

Subscribe to our newsletter